Related Experiment Video
Updated: Jun 6, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Role of complete lymphadenectomy in endometrioid uterine cancer
1University of California, San Francisco Comprehensive Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, CA, USA. Chanjohn@obgyn.ucsf.edu
The Lancet. Oncology
|September 4, 2007
Summary
Complete lymphadenectomy in uterine carcinoma offers prognostic value and guides treatment for node-positive patients. However, its necessity in low-risk cases requires further investigation due to potential complications.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Cancer Staging
Background:
- Surgical pathological staging is standard for uterine carcinoma.
- The role of complete lymphadenectomy in staging and treatment is debated.
- Complete lymphadenectomy provides prognostic information and guides adjuvant therapy for node-positive patients.
Purpose of the Study:
- To review the prognostic and therapeutic benefits of complete versus selective lymphadenectomy in uterine carcinoma.
- To discuss complications associated with lymphadenectomy.
- To identify low-risk patient subsets who may not require complete lymphadenectomy.
Main Methods:
- Literature review assessing evidence on lymphadenectomy benefits and complications.
- Analysis of prognostic and therapeutic impacts of complete vs. selective lymphadenectomy.
- Discussion of current limitations in preoperative and intraoperative pathological assessment.
Main Results:
- Complete lymphadenectomy aids in treatment decisions for node-positive uterine carcinoma patients.
- It can spare node-negative, low-risk patients from adjuvant treatment.
- Complications and limitations of pathological assessment complicate the decision for low-risk patients.
Conclusions:
- The benefit of complete lymphadenectomy in all uterine carcinoma patients, especially low-risk ones, is controversial.
- Further advancements in radiological and pathological assessments are needed to better identify nodal disease risk.
- Selective lymphadenectomy may be appropriate for specific low-risk patient groups.
